Burns Clinical Trial
Official title:
A Prospective, Randomized, Single Blinded, Controlled Clinical Investigation of James Embar® Light Therapy in the Treatment of Burn Wounds With Little Healing Potential
This will be a prospective, randomized, single blinded, controlled study in a single center setting to assess the effect of either phototherapy with the Embar® light therapy or sham irradiation.
This will be a prospective, randomized, single blinded, controlled study in a single center
setting. Patients with burn wounds will be screened for enrollment. All burn wounds that are
not clearly full thickness on clinical assessment will be treated the first 48 to 72 hours
with a hydrocolloid gel (Flaminal®) combined with Vaseline gauze. Wounds will be
photographed on a daily basis. In order to obtain an optimal preparation for Laser Doppler
imaging, the burn wounds will be meticulously debrided during dressing changes. Patients
whose burn wound meet the inclusion criteria will be randomized to receive either
phototherapy with the Embar® light therapy or sham irradiation. Disinfection and topical
treatment of the wounds will be the same in both groups as well as the treatment regimen
after wound closure with special pressure garments and hydration.
Clinical wound assessments, wound tracings (if possible) and digital photographs will be
conducted at least twice a week till wound healing. Swabs will be taken on admission, the
day after laser Doppler imaging and from then on a weekly basis. Primary endpoint is
complete epithelialization of the wound, secondary endpoint is maturation of the scar after
one year. Follow-Ups will be performed one, three, six and twelve months after wound
closure. The treatment regimen will consist of custom made pressure garments and hydration
of the scar. Objective methods will be used during these follow-ups to evaluate elasticity
and color of the scar, this by using the Dermalab and the Dermaspectrometer, as well as the
Vancouver Scar Scale, a subjective method.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Completed |
NCT05276869 -
Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
|
||
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06076031 -
Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing
|
N/A | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT03113253 -
TRANexamic Acid to Reduce Bleeding in BURN Surgery
|
Phase 4 | |
Recruiting |
NCT04090424 -
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT03159182 -
Study of Silicone Material Inserts To Treat Burn Scars
|
N/A | |
Recruiting |
NCT02904941 -
Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns
|
N/A | |
Completed |
NCT02681757 -
Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01437852 -
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
|
Phase 1 | |
Completed |
NCT01214811 -
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
|
Phase 3 | |
Completed |
NCT01061502 -
Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
|
Phase 1/Phase 2 | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Terminated |
NCT00634166 -
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
|
Phase 4 | |
Terminated |
NCT00824681 -
Effect of Music Therapy on Families of Burn Patients
|
Phase 1 | |
Terminated |
NCT00464386 -
Continuous Glucose Monitoring (POC) in the ICU
|
N/A | |
Withdrawn |
NCT00216983 -
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
|
N/A |